Skip to content

Cancer Research Institute

Lloyd J. Old STAR Program

$1.25M over 5 years| Deadline: 15 January 2027 (124 days)|5 years

23:59 Eastern Time

Last updated:

Closes 15 Jan 2027. Add it to your calendar, then see what else you're eligible for. See my matches →

The Lloyd J. Old STAR Program provides up to $1.25 million over five years for mid-career cancer immunotherapy researchers to pursue high-risk, high-reward projects. Eligible applicants are tenure-track assistant professors with at least three years in role, or associate professors within their first three years, holding an MD, PhD, or MD/PhD and committing at least 80% time to research. The programme is open globally to researchers hosted at non-profit medical schools and research centres.

Details

Funder Cancer Research Institute
Budget $1.25M over 5 years
Deadline 15 January 2027
Duration 5 years
Consortium No - individual applicant, hosted by applicant's own tenure-track institution
Application Single stage application; invited candidates undergo virtual interview
Frequency Annual

Eligibility & scope

For mid-career, tenure-track assistant or associate professors (M.D., Ph.D., or equivalent) with 3 years in that position, working on high-risk, high-reward cancer immunotherapy research; requires minimum 80% research time commitment; research must be conducted at non-profit medical schools or research centers, US or abroad (no for-profit institutions).

Who Should Apply

  • Tenure-track assistant professors with 3+ years in role, or associate professors within first 3 years
  • Researchers with MD, PhD, or MD/PhD degree
  • Applicants committing minimum 80% time to research
  • Hosted at non-profit medical schools or research centres (US or internationally)
  • Cancer immunotherapy projects with significant scientific risk and potential reward

Key Dates

  • Deadline: 15 January 2027, 11:59 p.m. Eastern Time
  • Two-stage: initial application, then invited virtual interview in Spring 2027
  • Five-year project duration

Tips for Applicants

  • Emphasise the high-risk/high-reward framing explicitly, CRI funds conceptually novel immunotherapy approaches, not incremental extensions.
  • Include institutional verification of your tenure-track status and research-time allocation; panel confirms eligibility early.
  • Virtual interview panel will probe feasibility of ambitious aims; prepare a clear risk-mitigation narrative.

Frequently Asked Questions

Who is eligible for the Lloyd J. Old STAR Program?

Tenure-track assistant professors with at least 3 years in role, or associate professors within their first 3 years, holding an MD, PhD, or MD/PhD, with at least 80% time commitment to research. Host institution must be a non-profit medical school or research centre (US or abroad); for-profit institutions and adjunct/acting positions are not eligible.

How much does the Lloyd J. Old STAR Program provide?

Up to $1.25 million over five years, plus up to 10% indirect costs.

When is the Lloyd J. Old STAR Program deadline?

15 January 2027, 11:59 p.m. Eastern Time. If the deadline falls on a weekend, applications are accepted until the end of the following Monday.

What type of research does the Lloyd J. Old STAR Program fund?

High-risk, high-reward cancer immunotherapy research led by mid-career scientists.

Is the Lloyd J. Old STAR Program interview required?

Yes, selected applicants advance to a virtual interview in Spring 2027 as the second stage of evaluation.

cancer-immunotherapymid-careerhigh-risk-researchcrius-and-internationalfive-year-grant
View full call →

Summary generated by AI based on published grant information. Always verify details on the funder's website.

Similar grants

Browse all open grants →

Browse Related

Could Lloyd J. Old STAR Program be right for you?

See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.

See my matches free →